Furthermore, a vitro study demonstrates MSCs promote reversible metastatic enhancement in breast carcinoma through TME-driven CCL5/RANTES secretion, which activates CCR5-mediated paracrine signaling to potentiate cancer cell motility, invasion, and distant dissemination (58). This evidence concerns the gene CCL5 and breast carcinoma.